| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5955750 | Chest | 2013 | 7 Pages |
Abstract
CPFE was identified in 8% of patients with IPF and is a distinct, clinical phenotype with potential therapies that remain underutilized. Patients with CPFE and IPF and those with non-CPFE IPF have similar mortality.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christopher J. MD, Thomas MD, Brett M. MD, Brett MD, Joyce S. MD, Marta MD, Kirk D. MD, Talmadge E. MD, Jay MD, FCCP, Harold R. MD, FCCP,